The price-to-earnings ratio for HUTCHMED (China) Limited ADR (NASDAQ: HCM) is 73.16x, which is above its average ratio. Moreover, the 36-month beta value for HCM is 0.53. Analysts have varying opinions on the stock, with 9 analysts rating it as a “buy”, 1 as “overweight”, 3 as “hold”, and 0 as “sell”.
The public float for HCM is 170.42M and currently, short sellers hold a 0.26% of that float. On July 04, 2025, HCM’s average trading volume was 91.92K shares.
HCM stock’s latest price update
The stock price of HUTCHMED (China) Limited ADR (NASDAQ: HCM) has jumped by 0.76% compared to previous close of $15.69. Despite this, the company has seen a gain of 3.06% in its stock price over the last five trading days. globenewswire.com reported 2025-07-03 that HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 03, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months ended June 30, 2025 on Thursday, August 7, 2025 at 7:00 am Eastern Daylight Time (EDT) / 12:00 noon British Summer Time (BST) / 7:00 pm Hong Kong Time (HKT).
HCM’s Market Performance
HUTCHMED (China) Limited ADR (HCM) has seen a 3.06% rise in stock performance for the week, with a 7.55% gain in the past month and a -0.57% plunge in the past quarter. The volatility ratio for the week is 1.97%, and the volatility levels for the past 30 days are at 2.36% for HCM. The simple moving average for the last 20 days is -0.21% for HCM’s stock, with a simple moving average of -0.41% for the last 200 days.
Analysts’ Opinion of HCM
Goldman gave a rating of “Neutral” to HCM, setting the target price at $46 in the report published on September 22nd of the previous year.
HCM Trading at 6.52% from the 50-Day Moving Average
After a stumble in the market that brought HCM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -26.47% of loss for the given period.
Volatility was left at 2.36%, however, over the last 30 days, the volatility rate increased by 1.97%, as shares surge +3.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.35% upper at present.
During the last 5 trading sessions, HCM rose by +3.06%, which changed the moving average for the period of 200-days by -8.56% in comparison to the 20-day moving average, which settled at $15.84. In addition, HUTCHMED (China) Limited ADR saw -9.97% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
N/A, the N/A of HUTCHMED (China) Limited ADR, N/A N/A shares at N/A during a trade that took place back on N/A, which means that N/A is holding N/A shares at N/A based on the most recent closing price.
Stock Fundamentals for HCM
Current profitability levels for the company are sitting at:
- -0.16% for the present operating margin
- 0.24% for the gross margin
The net margin for HUTCHMED (China) Limited ADR stands at -0.02%. The total capital return value is set at -0.08%. Equity return is now at value 5.06%, with 2.95% for asset returns.
Based on HUTCHMED (China) Limited ADR (HCM), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -0.48.
Currently, EBITDA for the company is 14.11 million with net debt to EBITDA at 0.98. When we switch over and look at the enterprise to sales, we see a ratio of 5.91. The receivables turnover for the company is 2.73for trailing twelve months and the total asset turnover is 0.36. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.83.
Conclusion
To wrap up, the performance of HUTCHMED (China) Limited ADR (HCM) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
